Vimarsana
Biggest News Aggregation in the World

Bing Zhang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bing Zhang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bing Zhang Today - Breaking & Trending Today

Economics Needs a New Methodenstreit Based on Austrian Methodology - Vimarsana News

Economics Needs a New Methodenstreit Based on Austrian Methodology

The Methodenstreit between the Mengerian Austrian School and the German Historical School needs to be rejoined. Mainstream economists are embracing the

Source: mises.org
Indian rainbow community shines at Auckland pride events - Vimarsana News

Indian rainbow community shines at Auckland pride events

Members of the Indian community attending pride events in Auckland last weekend have welcomed New Zealand's inclusive approach to rainbow issues.

Source: rnz.co.nz
University of Nevada, Las Vegas (UNLV) - Vimarsana News

University of Nevada, Las Vegas (UNLV)

University of Nevada, Las Vegas (UNLV)News, press releases, and expert sources for journalists in science, medicine & business

Stripes in a flowing liquid crystal suggest a route to "chiral" fluids | MIT News | Massachusetts Institute of Technology - Vimarsana News

Stripes in a flowing liquid crystal suggest a route to "chiral" fluids | MIT News | Massachusetts Institute of Technology

An MIT study finds chiral structures, with mirror-image configurations, can emerge from nonchiral systems, suggesting new ways to engineer these materials.

Source: mit.edu
Ovarian Cancer: New Biological Markers Found That May Predict Which Patients Won't Respond to Chemotherapy - Vimarsana News

Ovarian Cancer: New Biological Markers Found That May Predict Which Patients Won't Respond to Chemotherapy

Using a novel proteogenomic strategy and a variety of machine learning tools, investigators from the Icahn School of Medicine at Mount Sinai and colleagues have identified a 64-protein signature that may predict a subset of ovarian cancer patients who are unlikely to respond to chemotherapy.